SEC Form D · filed May 23, 2022
InflammX Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
James Blair · Tampa, FLDirectorDavid Boyer · Tampa, FLDirectorRajiv Shukla · Tampa, FLDirectorJason Werner · Tampa, FLDirectorBrian Levy · Tampa, FLExec · DirectorPhil Rosenfeld · Tampa, FLDirectorDavid Pool · Tampa, FLExecMichael Ivey · MCLEAN, VADirectorRicky Sim · Tokyo, M0Exec · DirectorKoichi Tsukui · Tokyo, M0DirectorIsao Sasaki · Tokyo, M0DirectorKeith Hardwick · Tokyo, M0ExecKouichi Nanba · Tokyo, M0DirectorSayaka Sumida · Tokyo, M0DirectorRichard Rubino · Ipswich, MADirectorPost Chad · Birmingham, ALExec · DirectorSamuel G. Sawhook · Corpus Christi, TXExecThibault Manekin · BALTIMORE, MDDirectorMike Vergato · Goffstown, NHDirectorAlan Jerusalmi · Goffstown, NHDirectorThomas Colarusso · Goffstown, NHDirectorBrad Mcgill · New York, NYDirectorRichard Rubino · Ipswich, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗